These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 4358084)

  • 1. Conformational studies on modified proteins and peptides. VII. Conformation of epsilon-prototoxin and epsilon-toxin from Clostridium perfringens. Conformational changes associated with toxicity.
    Habeeb AF; Lee CL; Atassi MZ
    Biochim Biophys Acta; 1973 Oct; 322(2):245-50. PubMed ID: 4358084
    [No Abstract]   [Full Text] [Related]  

  • 2. Clostridium perfringens type D epsilon prototoxin. Some chemical, immunological and biological properties of a highly purified prototoxin.
    Worthington RW; Mülders MS; Van Rensburg JJ
    Onderstepoort J Vet Res; 1973 Dec; 40(4):143-9. PubMed ID: 4369870
    [No Abstract]   [Full Text] [Related]  

  • 3. Clostridium perfringens exotoxins. II. Purification and some properties of theta-toxin.
    Mitsui K; Mitsui N; Hase J
    Jpn J Exp Med; 1973 Oct; 43(5):377-91. PubMed ID: 4359556
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on epsilon-prototoxin of Clostridium perfringens type D. Physicochemical and chemical properties of epsilon-prototoxin.
    Habeeb AF
    Biochim Biophys Acta; 1975 Nov; 412(1):62-9. PubMed ID: 172146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homology between enterotoxin protein and spore structural protein in Clostridium perfringens type A.
    Frieben WR; Duncan CL
    Eur J Biochem; 1973 Nov; 39(2):393-401. PubMed ID: 4359628
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on epsilon-prototoxin of Clostridium perfringens type D. I. Purification methods: evidence for multiple forms of epsilon-prototoxin.
    Habeeb AF
    Arch Biochem Biophys; 1969 Mar; 130(1):430-40. PubMed ID: 4305163
    [No Abstract]   [Full Text] [Related]  

  • 7. Tryptophan content of Clostridium perfringens epsilon toxin.
    Sakurai J; Nagahama M
    Infect Immun; 1985 Jan; 47(1):260-3. PubMed ID: 2856914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium perfringens exotoxins. I. Purification and properties of -toxin.
    Mitsu K; Mitsui N; Hase J
    Jpn J Exp Med; 1973 Apr; 43(2):65-80. PubMed ID: 4352113
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential conformational environment of tryptophan in epsilon native prototoxin and active toxin from Clostridium perfringens type D.
    Kumar A; Kumar S; Sarma Dagger PV; Sharma Double Dagger AK
    J Biochem Mol Biol Biophys; 2002 Apr; 6(2):147-50. PubMed ID: 12186772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides.
    Minami J; Katayama S; Matsushita O; Matsushita C; Okabe A
    Microbiol Immunol; 1997; 41(7):527-35. PubMed ID: 9272698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characterization of a protein fraction that chromatographically precedes the Clostridium perfringens toxin spore].
    Mayorga Corredor I; Torres-Anjel MJ; Figueroa J
    Rev Latinoam Microbiol; 1978; 20(1):13-24. PubMed ID: 220690
    [No Abstract]   [Full Text] [Related]  

  • 12. Purification and some properties of kappa toxin of Clostridium perfringens.
    Kameyama S; Akama K
    Jpn J Med Sci Biol; 1971 Feb; 24(1):9-23. PubMed ID: 4325624
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunochemistry of sperm-whale myoglobin. XVII. Conformation and immunochemistry of derivatives modified at lysines 98, 140 and 145 by reaction with 3,3-tetramethyleneglutaric anhydride.
    Atassi MZ; Perlstein MT; Staub DJ
    Biochim Biophys Acta; 1973 Dec; 328(2):278-88. PubMed ID: 4204632
    [No Abstract]   [Full Text] [Related]  

  • 14. Sugar transport. V. A trimeric lactose-specific phosphocarrier protein of the Staphylococcus aureus phosphotransferase system.
    Hays JB; Simoni RD; Roseman S
    J Biol Chem; 1973 Feb; 248(3):941-56. PubMed ID: 4684715
    [No Abstract]   [Full Text] [Related]  

  • 15. Purification of Clostridium perfringens type C theta toxin.
    Hauschild AH; Lecroisey A; Alouf JE
    Can J Microbiol; 1973 Aug; 19(8):881-5. PubMed ID: 4356555
    [No Abstract]   [Full Text] [Related]  

  • 16. Purification of phospholipase C (alpha-toxin) from Clostridium perfringens.
    Möllby R; Wadström T
    Biochim Biophys Acta; 1973 Oct; 321(2):569-84. PubMed ID: 4357667
    [No Abstract]   [Full Text] [Related]  

  • 17. Snake venom toxins. The amino acid sequences of two toxins from Dendroaspis jamesoni kaimosae (Jameson's mamba) venom.
    Strydom AJ
    Biochim Biophys Acta; 1973 Dec; 328(2):491-509. PubMed ID: 4204636
    [No Abstract]   [Full Text] [Related]  

  • 18. Denaturation of bovine carbonic anhydrase B by guanidine hydrochloride. A process involving separable sequential conformational transitions.
    Wong KP; Tanford C
    J Biol Chem; 1973 Dec; 248(24):8518-23. PubMed ID: 4202778
    [No Abstract]   [Full Text] [Related]  

  • 19. Conformational studies on modified proteins and peptides. V. Conformation of myoglobin derivatives modified at two carboxyl groups.
    Atassi MZ; Singhal RP
    J Biol Chem; 1972 Sep; 247(18):5980-6. PubMed ID: 5066543
    [No Abstract]   [Full Text] [Related]  

  • 20. Enzymatic activation of Clostridium perfringens epsilon prototoxin and some biological properties of activated toxin.
    Worthington RW; Mülders MS; Van Rensburg JJ
    Onderstepoort J Vet Res; 1973 Dec; 40(4):151-4. PubMed ID: 4369993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.